GB2331098A - An N-Alkylation process - Google Patents
An N-Alkylation process Download PDFInfo
- Publication number
- GB2331098A GB2331098A GB9723646A GB9723646A GB2331098A GB 2331098 A GB2331098 A GB 2331098A GB 9723646 A GB9723646 A GB 9723646A GB 9723646 A GB9723646 A GB 9723646A GB 2331098 A GB2331098 A GB 2331098A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compound
- boron
- diol
- alkylating agent
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 39
- 238000007126 N-alkylation reaction Methods 0.000 title claims abstract description 27
- 239000000758 substrate Substances 0.000 claims abstract description 41
- 239000002168 alkylating agent Substances 0.000 claims abstract description 36
- 229940100198 alkylating agent Drugs 0.000 claims abstract description 36
- 229910052796 boron Inorganic materials 0.000 claims abstract description 36
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000002243 precursor Substances 0.000 claims abstract description 7
- 150000002009 diols Chemical group 0.000 claims description 36
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 24
- 239000004327 boric acid Substances 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 238000005804 alkylation reaction Methods 0.000 claims description 9
- 150000002894 organic compounds Chemical class 0.000 claims description 7
- 239000003223 protective agent Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 230000029936 alkylation Effects 0.000 claims description 4
- 125000003368 amide group Chemical group 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims description 4
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 claims description 3
- 125000000466 oxiranyl group Chemical group 0.000 claims description 3
- KQIGMPWTAHJUMN-UHFFFAOYSA-N 3-aminopropane-1,2-diol Chemical compound NCC(O)CO KQIGMPWTAHJUMN-UHFFFAOYSA-N 0.000 claims description 2
- 150000002829 nitrogen Chemical class 0.000 claims description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims 1
- 229940126062 Compound A Drugs 0.000 description 63
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 63
- 239000000243 solution Substances 0.000 description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 28
- 235000010338 boric acid Nutrition 0.000 description 23
- 229960001025 iohexol Drugs 0.000 description 21
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 19
- 239000011541 reaction mixture Substances 0.000 description 19
- 238000004128 high performance liquid chromatography Methods 0.000 description 16
- 239000007864 aqueous solution Substances 0.000 description 15
- -1 boron diol Chemical class 0.000 description 12
- 229960000824 iopentol Drugs 0.000 description 12
- IUNJANQVIJDFTQ-UHFFFAOYSA-N iopentol Chemical compound COCC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I IUNJANQVIJDFTQ-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 229960004359 iodixanol Drugs 0.000 description 11
- NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 description 11
- 239000002585 base Substances 0.000 description 10
- 238000010511 deprotection reaction Methods 0.000 description 10
- 239000006227 byproduct Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 8
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 125000003545 alkoxy group Chemical group 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 5
- 125000000547 substituted alkyl group Chemical group 0.000 description 5
- AMDBBAQNWSUWGN-UHFFFAOYSA-N Ioversol Chemical compound OCCN(C(=O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I AMDBBAQNWSUWGN-UHFFFAOYSA-N 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 4
- 229960004537 ioversol Drugs 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 150000000185 1,3-diols Chemical group 0.000 description 3
- FOLYKNXDLNPWGC-UHFFFAOYSA-N 1-chloro-3-methoxypropan-2-ol Chemical compound COCC(O)CCl FOLYKNXDLNPWGC-UHFFFAOYSA-N 0.000 description 3
- LKMJVFRMDSNFRT-UHFFFAOYSA-N 2-(methoxymethyl)oxirane Chemical compound COCC1CO1 LKMJVFRMDSNFRT-UHFFFAOYSA-N 0.000 description 3
- SSZWWUDQMAHNAQ-UHFFFAOYSA-N 3-chloropropane-1,2-diol Chemical compound OCC(O)CCl SSZWWUDQMAHNAQ-UHFFFAOYSA-N 0.000 description 3
- BRARRAHGNDUELT-UHFFFAOYSA-N 3-hydroxypicolinic acid Chemical compound OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 description 3
- 101100007699 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) creB gene Proteins 0.000 description 3
- 101100402271 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) molB gene Proteins 0.000 description 3
- 238000010934 O-alkylation reaction Methods 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229910021538 borax Inorganic materials 0.000 description 3
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000004328 sodium tetraborate Substances 0.000 description 3
- 235000010339 sodium tetraborate Nutrition 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 229910015444 B(OH)3 Inorganic materials 0.000 description 2
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 230000002152 alkylating effect Effects 0.000 description 2
- 150000001642 boronic acid derivatives Chemical class 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002118 epoxides Chemical group 0.000 description 2
- 150000003944 halohydrins Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000004043 oxo group Chemical group O=* 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- ONHLDCLMLGMSNE-UHFFFAOYSA-N 1-$l^{1}-oxidanylethylidenehydrazine Chemical compound C\C([O])=N/N ONHLDCLMLGMSNE-UHFFFAOYSA-N 0.000 description 1
- CIUUPJHGWDRPKJ-UHFFFAOYSA-N 2,4,5-triiodobenzene-1,3-dicarboxamide Chemical compound NC(=O)C1=CC(I)=C(I)C(C(N)=O)=C1I CIUUPJHGWDRPKJ-UHFFFAOYSA-N 0.000 description 1
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 1
- DYPJJAAKPQKWTM-UHFFFAOYSA-N 2-chloropropane-1,3-diol Chemical compound OCC(Cl)CO DYPJJAAKPQKWTM-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000295146 Gallionellaceae Species 0.000 description 1
- 101000610640 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp3 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910020246 KBO2 Inorganic materials 0.000 description 1
- ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 description 1
- 101001110823 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-A Proteins 0.000 description 1
- 101000712176 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-B Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102100040374 U4/U6 small nuclear ribonucleoprotein Prp3 Human genes 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940051881 anilide analgesics and antipyretics Drugs 0.000 description 1
- 150000003931 anilides Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000012431 aqueous reaction media Substances 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- VGTPKLINSHNZRD-UHFFFAOYSA-N oxoborinic acid Chemical compound OB=O VGTPKLINSHNZRD-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- JVUYWILPYBCNNG-UHFFFAOYSA-N potassium;oxido(oxo)borane Chemical compound [K+].[O-]B=O JVUYWILPYBCNNG-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/08—Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A process for N-alkylation of a substrate to yield an N-alkyl group containing product comprises reacting said substrate with an alkylating agent containing an alkylatable group or a precursor therefor, characterised in that said substrate and/or said alkylating agent is reacted previously or simultaneously with a boron oxyacid, and in that said process further comprises deprotecting boron protected groups and optionally recovering said product.
Description
Process
This invention relates to a process for Nalkylation to introduce a group which is itself alkylatable, eg a hydroxyl-alkyl group, more particularly a process for such N-alkylation of compounds containing 1,2 and/or 1,3 diol structures.
Where N-alkylation is effected on a hydroxyl group containing substrate, even though N-alkylation occurs preferentially, competing O-alkylation reactions can occur resulting in reduced yield and undesired byproduct formation. Such N-alkylation is even more problematic where the alkyl group being introduced itself is hydroxylated as the N-alkylated product is susceptible to O-alkylation of the N-alkyl group that has been introduced.
Thus for example, in the case of pharmaceutical compounds prepared via multistep synthetic procedures, where N-hydroxy-alkylation is effected at a late stage in the synthetic procedure, the O-alkyl by-product formation significantly reduces production efficiency since the production of the N-alkylation substrate may have involved the use of expensive reagents and complex and time-consuming synthetic steps. Moreover since the
O-alkyl by-products frequently have very similar characteristics in terms of solubilities, etc. the work up of the N-alkylated product to remove these O-alkyl by-products involves significant use of equipment and time and may contribute to a further drop in overall yield.
This is particularly important in the case of the iodinated organic compounds, generally triiodophenyl compounds, which are used widely as contrast agents for
X-ray imaging. For these compounds, the expensive iodination step is usually effected at a late stage of the multistep synthesis but is generally followed directly or indirectly by N-alkylation of the nitrogens of one or more amide functions on the phenyl ring, commonly the nitrogen of an acylamino substituent.
The N-alkylated amide groups are important components of the overall contrast agent molecule in that they may impart water solubility to an otherwise highly lipophilic triiodophenyl structure.
Thus, by way of example, in the preparation of the
X-ray contrast agent iohexol described in GB-A-1548594, the triiodophenyl intermediate
(hereinafter "compound A"), is reacted in propylene glycol with the alkylating agent 1-chloro-2,3- propanediol to produce iohexol
IOHEXOL
In the preparation of iopentol, described in EP-A105752, compound A is reacted with the alkylating agent l-chloro-2-hydroxy-3-methoxy-propane, and in the preparation of iodixanol described in EP-A-108638 compound A is reacted with the alkylating (coupling) reagent epichlorohydrin.
In each case N-alkylation occurs at the acetyl amino nitrogen of compound A.
The N-hydroxy-alkylation of a hydroxyl group containing substrate such as compound A is accompanied by O-alkylation side reactions, generally as shown below in Scheme A (using for illustrative purposes the reaction to produce iohexol but, as in the subsequent
Schemes B to D, using a simplified formula to represent the parts of the molecule not involved in N- or O- alkylation).
SCHEME A
NH'COH LvROH LVROH Staning Material, NH OR eg Compound A \ LvROH OH H EWO LVROH < LvROH ROH (jH DESIRED PRODUCT \ I I EWG, %%011H LVROH 'YoR Nh \ \ ROH OH bH Lv LvROH EWG Y EWG ~Y OH '6"" OR ROH R-OH ROROH OH OH (where EWG is an electron withdrawig group, ROH is the hydroxyalkyl group being introduced, Lv is a leaving group, LvR-OH is the alkylating agent and Y is the rest of the molecule of the N-alkylation substrate).
Thus there is a need for an N-hydroxy-alkylation procedure which can be used with the polyhydroxylated intermediates in X-ray contrast agent synthesis, and in particular for a procedure which can be used with an aqueous rather than organic solvent system so as to reduce environmental problems.
We have now found that by using boron oxyacid (e.g. boric acid, borates, boronic acid, etc) as diol protecting agents, the N-hydroxy alkylation of such polyhydroxylated X-ray intermediates may be effected efficiently to produce products with a significant reduction in the production of O-alkyl by-products, and that moreover the N-hydroxy-alkylation reaction may be effected in water.
The difference in by-product formation is conveniently illustrated by the following scheme B, covering for example the conversion of compound A to iohexol using boron oxyacid diol protection.
SCHEME B
EwGNHYNŎH EWG, oOH OH Starting Material, ROH OH eg Compound A DESIRED PRODUCT B(OH)3 Deprotection yO \ OH, LVROH EWG, Y O-F(-OH ROll OH dH LVROH LVROH EWG \O LvROH EWG ys LvRHH I ROll OR OH OH OH OH OH Deprotection Deprotection NH'XOH EWG, OH OH ROH OH Starting Material DESIRED PRODUCT As can be seen by comparison of schemes A and B, using scheme B, after deprotection, the end products are essentially only the desired end product and the starting material (which can be recovered and reused).
The diol protecting boron oxyacid may furthermore be used to good effect when a substrate without diol groups is to be N-alkylated with a bis-hydroxy-alkyl group, as described below. In this context, the presence of a boron oxyacid diol protecting group in the
N-hydroxy alkylation reaction medium serves to inhibit formation of by-products in which the N-hydroxy-alkyl groups introduced in the reaction are subsequently 0alkylated. This may be seen from scheme C below:
SCHEME C
OH OH NH 2,3.HPA y'N,EWG ' $;3.HPA Y 'EW6 Y EWG N DESIRED PRODUCE X y EWG 1OH DESIRED OOH B(OH)3 0 Deprotection HO (4OH XOH y, NsEWG N EWG (where 2,3-HPA is a 2,3-bishydroxypropylating agent)
Thus viewed from one aspect the invention provides a process for N-alkylation of a substrate to yield an Nalkyl group containing product which comprises an alkylatable moiety in said N-alkyl group, said process comprising reacting said substrate with an alkylating agent containing an alkyl at able group or a precursor therefor, characterised in that said substrate and/or said alkylating agent is reacted previously or simultaneously with a boron oxyacid, and in that said process further comprises deprotecting boron-protected alkylatable groups, eg hydroxyl groups, and optionally recovering said product.
The substrate for the process of the invention need not but preferably does contain an N-hydroxy alkyl group, in particular a 1,2 or 1,3 diol group (ie. with hydroxyls attached to adjacent carbons in the substrate structure or to carbons separated by a further carbon in the substrate structure), more particularly a linear or branched thio or hydroxy C110, or more preferably C3 8,alkyl group, and most preferably a hydroxy C36 alkyl group. The alkyl group introduced by the alkylating agent in the process of the invention preferably contains a hydroxy group, in particular a 1,2 or 1,3 diol group, more particularly a linear or branched hydroxy Cll0, more preferably C3,alkyl group, or a precursor therefor, e.g. an oxirane group. The hydroxyalkyl groups introduced by the alkylating agent preferably contain two hydroxyl groups; nevertheless they may contain 1 or 3 or more hydroxyl groups.
In one preferred embodiment of the process of the invention, the substrate is an anilide with the ring attached nitrogen substituted by an electron withdrawing group, e.g. an acyl-anilide or sulphonyl-anilide. In an especially preferred embodiment, the substrate is an n, n+1 or n, n+2 bishydroxyalkylaminocarbonyl-acylanilide.
In this embodiment the process may comprise: reacting the n,n+l or n,n+2 bishydroxyalkylaminocarbonylacylanilide with a boron oxyacid and simultaneously or subsequently with the alkylating agent; subsequently deprotecting boron protected diol groups; and optionally recovering the N-alkylated bishydroxyalkylaminocarbonylacylanilide.
By n,n+1 and n,n+2 it is meant that the hydroxyalkyl groups referred to have hydroxy groups on neighbouring carbons or on carbons separated by one carbon atom. Such diol groups react with boron oxyacids to produce cyclic boron protected diol groups, e.g. groups of formula
(For simplicity, the negative charge on the boron and the countercation (ie. M+) are omitted in the formulae elsewhere in this text).
The n,n+l and n,n+2 bishydroxyalkyl groups may if desired contain more than two hydroxy groups - however where other hydroxy groups are present the boron diol protection will serve to reduce but may not entirely eliminate 0-alkyl by-product formation.
A further preferred embodiment of the process of the invention involves reacting an organic compound with a primary or secondary amino (or more preferably amido) compound with an alkylating agent which introduces a bis-hydroxyalkyl group. In this embodiment the process may conveniently involve: reacting the organic compound with a n,n+l or n,n+2 bishydroxyalkylating agent (e.g. a haloalkanol, or a haloalkyloxirane, for example epichlorohydrin, or analogs or derivatives thereof) in the presence of a boron oxyacid; subsequently deprotecting boron protected diol groups; and optionally recovering the N-bishydroxyalkylated organic compound.
The n,n+l and n,n+2 hydroxyalkyl groups in the substrates and end products of the processes of the invention preferably do not have hydroxyls on the a carbon, i.e. the nitrogen attached carbon.
The n,n+l and n,n+2 hydroxyalkyl groups in the substrates and end products of the processes of the invention conveniently contain 3 to 10 carbons, especially 3 to 6 carbons, and preferably 2, 3 or 4 hydroxyls, especially preferably 2 hydroxyls.
In the processes of the invention, the N-alkylation substrates are preferably compounds of formula I
where each A is independently hydrogen or halogen, more preferably, iodine; each R7 is independently a C16 hydroxyalkyl group, a group CONHR2 or a group NHR: optionally attached to the phenyl ring by an oxygen or sulphur atom or by a sulphoxide or sulphone group; each R1 is independently a hydrogen atom, a cyano group, an optionally hydroxy, alkoxy, halo, or aryl substituted alkyl group, an optionally hydroxy, halo, alkoxy or alkyl substituted aryl group or an acyl group, Rl preferably being a group R3CO, R3SO or R3SO2 (where R3 is an optionally hydroxy, halo, alkoxy or alkyl substituted aryl group or an optionally hydroxy, alkoxy, halo or aryl substituted alkyl group); and each R2 is independently a hydrogen atom or an optionally hydroxy, alkoxy, halo or aryl substituted alkyl group, at least one R2 preferably being a n,n+l or n,n+2 bishydroxyalkyl group.
In the compounds of formula I, each alkyl or alkylene moiety preferably contains 1 to 6 carbons; each halo substituent is preferably an iodine atom; each aryl group is preferably a 5 to 10 ring atom group optionally containing one, two or three ring heteroatoms selected from 0, N and S, especially preferably a phenyl group; and optional substitution includes substitution by more than one of the listed substituents.
Particularly preferred as N-alkylation substrates are compounds of formula Ia, Ib, Ic, Id, Ie and If
(where each R4 independently is a C3-5 hydroxyalkyl group having at least two hydroxyl groups on neighbouring carbons or on carbons separated by one other carbon; and each R5 is independently hydrogen or a C13 alkyl group).
Especially preferred as N-alkylation substrates are compounds of formula Ig
(where R, is hydroxymethyl, hydroxyethyl, 2,3-dihydroxy 1-propyl, l,3-dihydroxy-2-propyl or CONHR4; and each R4 is a 2, 3-dihydroxy-l-propyl, 1, 3-dihydroxy-2-propyl or 1,3,4-trihydroxy-2-butyl group), in particular compound
A.
In the processes of the invention, the alkylating agent used may be any compound capable of reacting with the nitrogen containing substrate to introduce an appropriately substituted alkyl group at a nitrogen atom. Preferably it contains the desired substituted alkyl group (or a precursor therefor) and a leaving group, e.g. a chlorine or an epoxy oxygen. Nitrogendisplaceable leaving groups are well known in synthetic organic chemistry. If desired, the alkylating agent may be a bifunctional agent, containing for example two leaving groups which may be the same or different, so that the N-alkylation reaction serves to couple together two molecules of the nitrogen containing substrate as in the synthesis of iodixanol. Particularly preferably, the alkylating agent contains a hydroxy group or a precursor therefor (e.g. an epoxide group, a protected hydroxyl group or an oxo group) and especially preferably it contains two or more, e.g. 2, 3 or 4, hydroxyl groups or precursors therefor. The "alkyl" moiety that the agent serves to introduce preferably contains 1 to 10 carbons, especially 1 to 8 carbons, particularly 2 to 6 carbons, unless alkylation involves coupling two aromatic molecules in which case the "alkyl" groups will conveniently contain up to 50 atoms, preferably up to 60 atoms. The alkylating agent may thus be represented by formula III LV-(CH (H) ,~,~, (Z),(LV),).H (III) where each Lv is a leaving group, optionally an oxygen atom which is also bonded to an adjacent carbon to produce an oxirane ring; m is 0 or 1; p is 0 or 1; Z is a hydrogen atom, a hydroxyl group or an organic moiety conveniently containing up to about 80 atoms, at least one Z being a hydroxy group; and n is 1 to 10; at least one p is 1 and the sum of all p's preferably being 1, 2 or 3. Where Z represents an organic moiety, this is preferably an alkyl or aryl group optionally attached via an oxygen or sulphur atom or an SO or SO2 group and optionally substituted by one or more groups selected from hydroxy, alkoxy, halo, oxo, cyano, alkyl, aryl, and oxyacid.
Particularly preferred alkylating agents are 1halo-2, 3-propanediols, e.g l-chloro-2, 3-propanediol, halohydrins, e.g epichlorohydrin, 2-halo-1, 3- propanediols, e.g 2-chloro-1, 3-propanediol, and 1-halo3-alkoxy-propan-2-ols, e.g l-chloro-3-methoxy-propan-2ol. Other appropriate alkylating agents are described by Bjrsvik et al. in Acta Chem Scand. 48 : 446-456 (1995).
The boron oxyacid used in the processes of the invention may be used in the free acid forms (e.g as boric acid, metaboric acid or a boronic acid) or as salts or esters. Examples of borates which may be used include borax, metaborate and ortho-borate. Mixtures of two or more such boron oxyacids may also be used. Where a boronic acid is used, the non-hydroxy substituent on the boron may be any convenient organic moiety, generally selected for its compatibility with the solvent system being used and for its relative nonreactivity with the alkylating agent being used, e.g. an optionally substituted phenyl or lower alkyl group. In general however the preferred diol protecting agent will be boric acid as it is inexpensive and readily obtainable.
The N-alkylation reaction of the processes of the invention can if desired be effected in a "one-pot" reaction with N-alkylation substrate, boron diol protecting agent and N-alkylating agent being reacted together simultaneously. Alternatively the diol protection reaction may be effected before the protected substrate, which may or may not be isolated first, is exposed to the N-alkylating agent. Diol deprotection may conveniently be effected by reducing the pH, e.g to below 5.
The diol deprotection reaction allows both the Nalkylated end product and the N-alkylation substrate to be recovered, in the latter case for optional recycling through diol protection, N-alkylation and diol deprotection.
The overall effect is thus to enable a higher ratio of N-alkylated end product to O-alkyl by-product to be achieved. Following diol deprotection, the boronated residues may readily be removed from the reaction mixture by filtration and reverse osmosis work-up.
Boric acid is a weak monovalent acid which readily esterfies to complex alkoxy borates. Generally such esters are stable in aqueous reaction media at pH's above about 7. In general the highest stability of boron protected diols in aqueous media occurs at the pH where the sum of the charges of the free esterifying species is equal to the charge of the ester. The rate of diol protection and deprotection is rapid.
The protected diols may comprise two diol species protected by the same boron.
In general in boron diol protection, the aqueous dilution of the reagents should be kept as low as possible to maximize the protection of the diol ester formation. However, the reaction medium must have an acceptable viscosity. Thus, by way of example for compound A as the N-alkylation substrate, water contents may be as low as 0.8, e.g. 0.9 to 1.0, mL/g substrate.
The quantity of boron diol protecting agent used will conveniently be at least 0.4 mol B/mol diol group in the substrate (i.e. at least 0.8 mol B/mol substrate where the substrate contains two n,n+1 or n,n+2 diol groups), preferably at least 0.5 molB/mol diol group, especially preferably at least 1.0 molB/mol diol group, e.g. 1.1 to 2.0 molB/mol diol group.
The diol protection is preferably effected in a neutral to alkaline medium, e.g pH 7 to 15, preferably pH 10 to 14. This may be achieved by inclusion of a tolerable base, e.g an alkali metal or alkaline earth metal hydroxide, but preferably a base which is not a primary or secondary amine. The base concentration is preferably at least equivalent to the boron diol protecting group concentration, e.g expressed as OH and H+ equivalents.
During the diol protection and N-alkylating reactions, the pH is preferably monitored and if necessary adjusted to maintain an alkaline level, e.g by addition of small quantities of base or boron diol protecting agent.
Optimal pH and base may be determined for particular N-alkylation substrate/N-alkylating agent combinations.
The quantity of N-alkylating agent used should generally be at least equivalent to the concentration of nitrogens to be N-alkylated, e.g an equivalent ratio of 1:1 to 1.5:1. The optimal ratio may be determined for particular N-alkylation substrate/N-alkylating agent combinations. The N-alkylating agent may be added in a single step, over a series of steps, or continuously.
In general, the processes of the invention are effected at temperatures in the range -20 to +1400C, preferably 0 to 600C. Thus, in a preferred embodiment,
N-alkylation substrate (1 equivalent N-H), base, boric acid and water are mixed. The order of mixing is not important but for acid N-H substrates the order water, base, substrate, boric acid is preferred. The quantity of boric acid, B, in equivalents is preferably the product of the number of protectable diol groups in the substrate and a number with a value in the range 0.5 to 2, preferably 1.0. The quantity, OH, of base (in OH equivalents) is preferably given by the equation
OH 5 (B + C)D + E where: C is the number of acidic nitrogen attached hydrogens in the starting material; D has the value 0 to 2, preferably 1.0; and E has the value 0-2, preferably 0 for epoxide or alkyl halide alkylating agents and 1 for halohydrin or dialkyl sulphate alkylating agents. For other boron sources than boric acid an appropriately modified version of this equation may be used, taking into account that, for borax or metaborate, hydrolysis yields base and boric acid.
The quantity of water used is preferably the minimum necessary to achieve a reaction mixture with an acceptable viscosity, e.g 0.3 to 5, preferably about 1,
L/kg substrate.
The mixing temperature is conveniently 0 to 1000C, preferably 20-50"C; the mixing time is dependent on the mixing temperature and is typically 1 to 24 hours, with mixing conveniently being effected until a clear homogeneous solution is obtained. However, in certain circumstances, the mixture may remain as a suspension.
The pH is measured and if necessary adjusted by addition of base or boric acid.
The mixture is then preferably brought to a reaction temperature in the range 0 to 600C, e.g 10 to 20"C.
The alkylating agent is then preferably added to a total amount, H, in equivalents given by
H = 1/F + G where F 2 1, preferably 1 for monoalkylating agents and 2 for bis-alkylating agents, and G is 0 to 1, preferably 0.01 to 0.2 (for the compensation of partial hydrolysis). As indicated above, addition may be stepwise or continuous.
During reaction, pH should desirably be monitored and adjusted if required.
The reaction time will depend on reaction temperature and is typically 2 to 72 hours, e.g 3 to 24 hours.
The reaction may be performed using a pH gradient and/or a temperature gradient, preferably a pH and temperature gradient.
Following the alkylating reaction, the reaction mixture may be worked up by dropping the pH to 5 or below, e.g by addition of hydrochloric acid. Boric acid precipitates and the dispersion is preferably cooled to OOC and maintained at that temperature for 1 to 24 hours, e.g 1 to 3 hours. The reaction mixture may then be filtered cold. Salts in the filtrate may be removed by reverse osmosis and/or ion exchange whereafter the solution may conveniently be evaporated to dryness to give a crude product. Pure N-alkylated end product may be recovered by conventional methods.
The process of the invention is also applicable to
N-alkylation of 1-amino-2,3-propane-diols and 2-amino1,3-propane-diols (APDs) in general, e.g compounds in which the nitrogen to be alkylated is or is attached indirectly to the amine nitrogen of the APD (for example as in compound A above), and to N-alkylation of the acylated nitrogen of n,n+l/n,n+2 diol substituted Nacyl-anilides in general. Such processes form further aspects of the invention.
The invention will now be described further with reference to the following non-limiting Examples:
Example 1
Iohexol
Compound A (1 eqv., 100 g) was dissolved in an aqueous solution of KOH (4.5 eqv., 33.8 g) in water (1.0 volume/weight compound A, 100 ml). Boric acid (2.5 eqv., 20.69 g) was added and the solution was stirred for 124h (preferably 18h) at 100C. The starting pH was > 14.
3-Chloro-1, 2-propanediol (1.10 eqv., 16.28 g) was added to the stirred solution at 100C. The reaction mixture was stirred at 100C and the pH dropped below 13. The pH was then stabilized in the range 12.6 - 13 by adding small amounts of boric acid (in total 0.14 eqv., 1.17 g). After 24h and 48h, samples of 50p1 were taken, diluted in a solution of conc. HC1 (5081) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24h: 78.28 % iohexol, 19.22 % compound A, 2.50 % others.
Results (area-%) after 48h: 86.83 % iohexol, 10.53 t compound A, 2.64 % others.
Example 2 I ohexol Compound A (1 eqv., 100 g) was dissolved in an aqueous solution of KOH (3.5 eqv., 26.29 g) in water (1.0 volume/weight compound A, 100 ml). Boric acid (2.5 eqv., 20.69 g) was added and the solution was stirred for 124h (preferably 18h) at 100C. The starting pH was about 12.4. Glycidol (1.03 eqv., 10.21 g) was added to the stirred solution at 100C. The reaction mixture was stirred at 100C and the pH drifted towards 13. The pH was then stabilized in the range 12.6 - 13 by adding small amounts of boric acid (in total 0.34 eqv., 2.86 g). After 24h and 48h, samples of 5041 were taken, diluted in a solution of conc. HC1 (5041) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24h: 72.75 % iohexol, 23.77 % compound A, 3.48 % others.
Results (area-%) after 48h: 78.63 % iohexol, 16.92 % compound A, 4.45 % others.
Example 3 (Comparative) I ohexol Compound A (1 eqv., 10 g) was dissolved in an aqueous solution of KOH (2 eqv., 1.50 g) in water (1.0 volume/weight compound A, 10 ml). 3-Chloro-1,2- propanediol (1.10 eqv., 1.63 g) was added to the stirred solution at 100C. The reaction mixture was stirred at 100C. After 24h and 48h, samples of 50p1 were taken, diluted in a solution of conc. HC1 (50y1) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24h: 65.5 % iohexol, 23.1 e compound A, 9.5 % others.
Results (area-%) after 48h: 67.1 e iohexol, 17.6 % compound A, 14.1 % others.
Example 4 (Comparative) lohexol Compound A (1 eqv., 10 g) was dissolved in an aqueous solution of KOH (1 eqv., 0.75 g) in water (1.0 volume/weight compound A, 10 ml). Glycidol (1.03 eqv., 1.02 g) was added to the stirred solution at 100C. The reaction mixture was stirred at 100C. After 24h and 48h, samples of 50y1 were taken, diluted in a solution of conc. HC1 (50 l) in water (14 ml), and analyzed by RP-18
HPLC. Results (area-%) after 24h: 55.3 % iohexol, 25.3 % compound A, 18.5 % others. Results (area-%) after 48h: 54.2 % iohexol, 28.2 % compound A, 16.4 t others.
Example 5 lopentol Compound A (1 eqv., 100 g) was dissolved in an aqueous solution of KOH (3.25 eqv., 24.41 g) in water (1.0 volume/weight compound A, 100 ml). Boric acid (2.75 eqv., 22.76 g) was added and the solution was stirred for 1-24h (preferably 18h) at 200C. The starting pH was about 11.7. Glycidyl methyl ether (1.03 eqv., 12.15 g) was added to the stirred solution at 200C. The reaction mixture was stirred at 200C. The pH increased but not above 13. After 24h and 48h, samples of 50y1 were taken, diluted in a solution of conc. HCl (50#1) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24h: 83.12 % iopentol, 11.07 % compound A, 5.81 % others. Results (area-%) after 48h: 85.83 % iopentol, 7.89 % compound A, 6.28 % others.
Example 6 lopentol Compound A (1 eqv., 100 g) was dissolved in an aqueous solution of KOH (4.0 eqv., 30.04 g) in water (1.0 volume/weight compound A, 100 ml). Boric acid (3. 0 eqv., 24.83 g) was added and the solution was stirred for 124h (preferably 18h) at 200C. The starting pH was about 12.4. 3-Chloro-l-methoxy-2-propanol (1.03 eqv., 17.17 g) was added to the stirred solution at 200C. The reaction mixture was stirred at 200C. The pH decreased but not below 10. After 24h and 48h, samples of 50y1 were taken, diluted in a solution of conc. HC1 (50p1) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after solution of KOH (0.5 eqv., 0.38 g) in water (1.0 volume/weight compound A, 10 ml). Glycidyl methyl ether (1.03 eqv., 1.21 g) was added to the stirred solution at 200C. The reaction mixture was stirred at 200C. After 24h and 48h, samples of 50y1 were taken, diluted in a solution of conc. HCl (50y1) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24h: 67.0 iopentol, 22.7 % compound A, 9.4 % others. Results (area-%) after 48h: 67.9 W iopentol, 20.3 % compound A, 10.9 % others.
Example 8 (Comparative) lopentol Compound A (1 eqv., 10 g) was dissolved in an aqueous solution of KOH (1.0 eqv., 0.75 g) in water (1.0 volume/weight compound A, 10 ml). Glycidyl methyl ether (1.03 eqv., 1.21 g) was added to the stirred solution at 200C. The reaction mixture was stirred at 200C. After 24h and 48h, samples of 50y1 were taken, diluted in a solution of conc. HCl (50y1) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24h: 57.0 % iopentol, 26.5 % compound A, 15.0 % others. Results (area-%) after 48h: 56.0 % iopentol, 20.3 % compound A, 16.1 * others.
Example 9 (Comparative) lopentol Compound A (1 eqv., 10 g) was dissolved in an aqueous solution of KOH (1.5 eqv., 1.13 g) in water (1.0 volume/weight compound A, 10 ml). 3-Chloro-l-methoxy-2propanol (1.03 eqv., 1.72 g) was added to the stirred solution at 200C. The reaction mixture was stirred at 200C. After 24h and 48h, samples of 50y1 were taken, diluted in a solution of conc. HCl (50y1) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24h: 76.1 % iopentol, 19.3 * compound A, 4.2 % others.
Results (area-%) after 48h: 81.7 % iopentol, 11.9 % compound A, 6.1 % others,
Example 10 (Comparative)
Iopentol
Compound A (1 eqv., 10 g) was dissolved in an aqueous solution of KOK (2.0 eqv., 1.50 g) in water (1.0 volume/weight compound A, 10 ml). 3-Chloro-l-methoxy-2propanol (1.03 eqv., 1.72 g) was added to the stirred solution at 200C. The reaction mixture was stirred at 200C. After 24h and 48h, samples of 50 l were taken, diluted in a solution of conc. HC1 (50y1) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24h: 65 % iopentol, 20 % compound A, 16 % others.
Results (area-%) after 48h: 64 % iopentol, 20 % compound
A, 16 % others.
Example 11 loversol
N,N'-Bis(2,3-dihydroxypropyl)-5-glycolam triiodoisophthalamide (compound F) (1 eqv., 7.0 g) was dissolved in an aqueous solution of KOH (5.5 eqv., 2.83 g) in water (1.0 volume/weight compound F, 7 ml). Boric acid (3.5 eqv., 1.99 g) was added and the solution was stirred for 1-24h (preferably 18h) at 200C. 2-Chloro-lethanol (1.05 eqv., 0.78 g, 0.644 ml) was added to the stirred solution at 200C. The reaction mixture was stirred at 200C. After 24h and 48h, samples of 50 l were taken, diluted in a solution of conc. HCl (50 l) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24h: 67.8 % ioversol, 12.8 % compound F, 19.4 8 others. Results (area-%) after 48h: 67.5 % ioversol, 11.1 % compound F, 21.4 % others.
Example 12 (Comparative) loversol Compound F (1 eqv., 7.0 g) was dissolved in an aqueous solution of KOH (2 eqv., 1.03 g) in water (1.0 volume/weight compound F, 7 ml). 2-Chloro-1-ethanol (1.05 eqv., 0.78 g, 0.644 ml) was added to the stirred solution at 200C. The reaction mixture was stirred at 200C. After 24h and 48h, samples of 50y1 were taken, diluted in a solution of conc. HCl (50 l) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24h: 39.2 % ioversol, 23.4 % compound F, 37.4 % others.
Results (area-%) after 48h: 37.6 % ioversol, 23.2 compound F, 39.2 % others.
Example 13 lodixanol Compound A (1 eqv., 100g) was dissolved in an aqueous solution of KOH (3.0 eqv., 22.53g) in water (0.9 volume/ weight Compound A, 90 ml). Boric acid (2.0 eqv., 16.55g) was added and the solution was stirred for 1 to 24 hours, preferably 18 hours, at 100C. The starting pH = 12.93. Epichlorohydrin (0.57 eqv., 7.046g) was added to the stirred solution at IOOC. The reaction mixture was stirred at 10 C and the pH was stabilized in the range 12.6-13. After 24 hours and 48 hours samples of 50 l were taken, diluted in a solution of conc. HCl (50 p1) in water (14 ml), and analyzed by RP-18 HPLC.
Results (area-%) after 24 hours: 80.5 Iodixanol, 6.9%
Compound A, 7.5% Iohexol, 5.1% others. Results (area-%) after 48 hours: 83.4% Iodixanol, 2.5% Compound A, 8.9
Iohexol, 5.2% others.
Example 14
Iodixanol
Compound A (1 eqv., 100g) was dissolved in an aqueous solution of borax K2BgO74H20 (2.0 B-eqv., 20.45g) in water (1.0 volume/weight Compound A, 100 ml). KOH (2.0 eqv., 15.02g) was added and the solution was stirred for 1 to 24 hours, preferably 18 hours, at 100C. Starting pH = 12.86. Epichlorohydrin (0.55 eqv., 6. 80g) was added to the stirred solution at 10 C. The reaction mixture was stirred at 100C and the pH was stabilized in the range 12.6-13 by addition of small amounts of boric acid or KOH. After 24 hours and 48 hours, samples of 50 l were taken, diluted in a solution of conc. HCl (50 l) in water (14 ml), and analyzed by RP-18 HPLC.
Results (area-%) after 24 hours: 80. 6% Iodixanol, 8.9% Compound A, 6. 1% Iohexol, 4.4% others. Results (area-%) after 48 hours: 83.4% Iodixanol, 4. 7W Compound A, 7.1% Iohexol, 4.8% others.
Example 15 lodixanol Compound A (1 eqv., 100g) was dissolved in an aqueous solution of potassium metaborate KBO2. H20 (2.0 B-eqv., 26.75g) in water (1.0 volume/weight Compound A, 100 ml).
KOH (1.0 eqv., 7.51g or less) was added to the stirred solution until the pH was stabilized in the range 12.613. The solution was stirred 1 to 24 hours, preferably 18 hours, at 100C. Starting pH = 12.71.
Epichlorohydrin (0.55 eqv., 6.80g) was added to the stirred solution at 10 C. The reaction mixture was stirred at 100C and the pH was stabilized in the range 12.6-13 by addition of small amounts of boric acid or
KOH. After 24 hours and 48 hours, samples of 50 l were taken, diluted in a solution of conc. HCl (50 pl) in water (14 ml), and analyzed by RP-18 HPLC. Results (area-%) after 24 hours: 79.8 Iodixanol, 8.7% Compound
A, 6.8 % Iohexol, 4.7% others. Results (area-%) after 48 hours: 83.3% Iodixanol, 3.8% Compound A, 7,8% Iohexol, 5.1% others.
Example 16 (Comparative)
Iodixanol
Compound A (1 eqv., 100g) was dissolved in an aqueous solution of sodium hydroxide (1.2 eqv., 6.43g) in water (3.0 volume/weight Compound A, 300 ml). The solution was stirred 1 to 24 hours, preferably 18 hours, at 250C.
Epichlorohydrin (0.5 eqv., 6.181g) was added to the stirred solution at 250C and stirring continued. After 24 hours 150 l were taken, diluted in a solution of conc. HC1 (50 Fl) in water (14 ml), and analyzed by RP18 HPLC. Results (area-%) after 24 hours: 49.1% Iodixanol, 25. 1% Compound A, 9.1% Iohexol, 16.7% others.
Claims (7)
- Claims 1. A process for N-alkylation of a substrate to yield an N-alkyl group containing product which comprises an alkylatable moiety in said N-alkyl group, said process comprising reacting said substrate with an alkylating agent containing an alkyl at able group or a precursor therefor, characterised in that said substrate and/or said alkylating agent is reacted previously or simultaneously with a boron oxyacid, and in that said process further comprises deprotecting boron protected groups and optionally recovering said product.
- 2. A process as claimed in claim 1 for the Nalkylation of a n,n+1 or n,n+2 bishydroxyalkylaminocarbonyl -acylanilide, which process comprises reacting a n,n+l or n,n+2 bishydroxyalkylaminocarbonyl-acylanilide with a boron oxyacid and simultaneously or subsequently with an alkylating agent, subsequently deprotecting boron protected diol groups, and optionally recovering the Nalkylated bishydroxyalkylaminocarbonyl-acylanilide.
- 3. A process as claimed in claim 1 or claim 2 for Nbishydroxyalkylation of an organic compound having a primary or secondary amino (or amido) group, said process comprising reacting an organic compound having a primary or secondary amino (or amido) group with a n,n+1 or n,n+2 bishydroxyalkylating agent in the presence of a boron oxyacid, subsequently deprotecting boron protected diol groups, and optionally recovering the Nbishydroxyalkylated organic compound,
- 4. A process for the N-alkylation of a 1-amino-2,3- propanediol or 2-amino-1,3-propanediol using an alkylating agent, characterised in that said l-amino2,3-propanediol or 2-amino-1,3-propanediol is contacted with a boron oxyacid diol protecting agent before or simultaneously with contact with said alkylating agent.
- 5. A process for the alkylation of the acylated nitrogen of a n,n+1 or n,n+2 diol substituted N-acylanilide using an alkylating agent, characterised in that said n,n+l or n,n+2 diol substituted N-acyl-anilide is contacted with a boron oxyacid diol protecting agent before or simultaneously with contact with said alkylating agent.
- 6. A process as claimed in any one of claims 1 to 5 wherein said boron oxyacid is boric acid or a borate.
- 7. A process as claimed in any one of claims 1 to 6 wherein said alkylating agent is an oxirane or an n,n+2 or n,n+1 diol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9723646A GB2331098A (en) | 1997-11-07 | 1997-11-07 | An N-Alkylation process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9723646A GB2331098A (en) | 1997-11-07 | 1997-11-07 | An N-Alkylation process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9723646D0 GB9723646D0 (en) | 1998-01-07 |
| GB2331098A true GB2331098A (en) | 1999-05-12 |
Family
ID=10821796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9723646A Withdrawn GB2331098A (en) | 1997-11-07 | 1997-11-07 | An N-Alkylation process |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2331098A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2277853A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Synthesis of iodixanol in methanol |
| EP2277854A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Synthesis of iodixanol in 1-methoxy-2-propanol and water or methanol |
| EP2277852A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Synthesis of iodixanol in water |
| EP2279998A1 (en) * | 2009-07-21 | 2011-02-02 | GE Healthcare AS | Synthesis of iodixanol in propyleneglycol |
| KR20120105015A (en) * | 2009-11-26 | 2012-09-24 | 호비온 차이나 홀딩 리미티드 | Preparation and purification of iodixanol |
| US9950991B2 (en) | 2013-11-05 | 2018-04-24 | Bracco Imaging S.P.A. | Process for the preparation of iopamidol |
| CN110054569A (en) * | 2019-05-17 | 2019-07-26 | 浙江海洲制药有限公司 | A method of preparing Iohexol |
-
1997
- 1997-11-07 GB GB9723646A patent/GB2331098A/en not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| Chem Abs.90:121141, J.Org. Chem.(1979), 44(5), 875-7. CODEN: JOCEAH * |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8962886B2 (en) | 2009-07-21 | 2015-02-24 | Ge Healthcare As | Synthesis of iodixanol in methanol |
| US8969619B2 (en) | 2009-07-21 | 2015-03-03 | Ge Healthcare As | Synthesis of iodixanol in propyleneglycol |
| EP2277852A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Synthesis of iodixanol in water |
| US8962887B2 (en) | 2009-07-21 | 2015-02-24 | Ge Healthcare As | Synthesis of iodixanol in 1-methoxy-2-propanol and water or methanol |
| CN101962335A (en) * | 2009-07-21 | 2011-02-02 | 通用电气医疗集团股份有限公司 | Synthetic Visipaque 320 in propylene glycol |
| CN102001965A (en) * | 2009-07-21 | 2011-04-06 | 通用电气医疗集团股份有限公司 | Synthesis of iodixanol in water |
| CN101962335B (en) * | 2009-07-21 | 2015-11-25 | 通用电气医疗集团股份有限公司 | Visipaque 320 is synthesized in propylene glycol |
| CN102001965B (en) * | 2009-07-21 | 2015-09-02 | 通用电气医疗集团股份有限公司 | Visipaque 320 is synthesized in water |
| EP2277854A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Synthesis of iodixanol in 1-methoxy-2-propanol and water or methanol |
| EP2277853A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Synthesis of iodixanol in methanol |
| EP2279998A1 (en) * | 2009-07-21 | 2011-02-02 | GE Healthcare AS | Synthesis of iodixanol in propyleneglycol |
| JP2013512196A (en) * | 2009-11-26 | 2013-04-11 | ホビオネ チャイナ ホールディング リミテッド | Preparation and purification of iodixanol |
| KR20120105015A (en) * | 2009-11-26 | 2012-09-24 | 호비온 차이나 홀딩 리미티드 | Preparation and purification of iodixanol |
| KR101699226B1 (en) * | 2009-11-26 | 2017-01-24 | 호비온 차이나 홀딩 리미티드 | Preparation and purification of iodixanol |
| US9950991B2 (en) | 2013-11-05 | 2018-04-24 | Bracco Imaging S.P.A. | Process for the preparation of iopamidol |
| EP3369724A1 (en) | 2013-11-05 | 2018-09-05 | Bracco Imaging SPA | Process for the preparation of iopamidol |
| US10377700B2 (en) | 2013-11-05 | 2019-08-13 | Bracco Imaging S.P.A. | Process for the recovery of a boronic acid |
| CN110054569A (en) * | 2019-05-17 | 2019-07-26 | 浙江海洲制药有限公司 | A method of preparing Iohexol |
| CN110054569B (en) * | 2019-05-17 | 2022-05-17 | 浙江海洲制药有限公司 | Method for preparing iohexol |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9723646D0 (en) | 1998-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI88026C (en) | Process for preparing etherified polyoxyalkylene derivatives | |
| WO1988009328A1 (en) | Preparation of 5-acylamino-2,4,6-triiodo- or tribromo-benzoic acid derivatives | |
| GB2066245A (en) | Process for preparing hydroxyalkylaminosulphonic acids | |
| GB2331098A (en) | An N-Alkylation process | |
| US4982000A (en) | Process for preparing quaternary ammonium compounds | |
| EP4172139B1 (en) | Process for the preparation of iopamidol | |
| JP2531519B2 (en) | Method for producing oxamide derivative | |
| US6060623A (en) | Process for producing amine borane compound | |
| Priebe | An N-Alkylation process | |
| AU664090B2 (en) | Process for the preparation of polyoxyalkylated amines | |
| US6054615A (en) | Fluorinated quaternary ammonium salts | |
| US4429160A (en) | Polyoxaalkyl aminoalcohols | |
| JPH02115151A (en) | Oduction of alpha-aminoalkanol | |
| EP0699190B1 (en) | Preparation of 3-mercapto-5-amino-1h-1,2,4-triazole | |
| EP1727787A2 (en) | New process for the preparation of nitrooxyderivatives of paracetamol | |
| JPH03181448A (en) | Preparation of polyoxyalkyleneglycolamine | |
| JP4336157B2 (en) | Novel 4,4 "-di (hydroxyalkoxy) terphenyls | |
| GB2108106A (en) | Novel macrocyclic compounds and salts thereof useful for dissolving barium sulphate scale | |
| CA1130305A (en) | Process for the preparation of n,n'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein | |
| JP3161793B2 (en) | New aminopolycarboxylic acid derivatives | |
| US4197410A (en) | N-[(N-Nitrosoalkylamino)methyl]carbamic acid esters for generating diazoalkanes | |
| JP3224282B2 (en) | Aminopolycarboxylic acid derivative | |
| JPS58128356A (en) | 2-alkoxymethylene-3,3-dialkoxypropanenitriles | |
| AU686170B2 (en) | Preparation of symmetrical or unsymmetrical disubstituted N-cyanodithioiminocarbonates | |
| KR860002109B1 (en) | Method for preparing N-phosphono methyl glycine salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |